Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals
- 19 February 2008
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (4) , 489-496
- https://doi.org/10.1097/qad.0b013e3282f47082
Abstract
Objective: To investigate trends, patient characteristics, and survival associated with AIDS-defining cancer (ADC) and non-AIDS defining cancer (NADC) in the HAART era. Design: Retrospective analysis of all incident malignancies occurring in 1996–2005 among 2566 patients in an urban HIV clinic. Methods: Clinical profiles of NADC were compared with ADC and the general cohort. Incidence was examined by Poisson analysis. Standardized incidence ratios (SIR) compared cancer risk with that in the general population. Survival was analyzed by Kaplan–Meier and Cox proportional hazards models. Results: Between 1996 and 2005, 138 ADC and 115 NADC were diagnosed. ADC rates decreased from 12.5 to 3.5 cases/1000 person-years (P < 0.001 for trend) while NADC rates increased from 3.9 to 7.1 cases/1000 person-years (P = 0.13 for trend). Incidence of the most common NADC was higher than expected, including cancers of the lung [n = 29; SIR, 5.5; 95% confidence interval (CI), 3.7–8.0], liver (n = 13, SIR, 16.5; 95% CI, 8.8–28.2), anus (n = 10; SIR, 39.0; 95% CI, 18.7–71.7), head and neck (n = 14; SIR, 5.1; 95% CI, 2.8–8.6), and Hodgkin's lymphoma (n = 8; SIR, 9.8; 95% CI, 4.2–19.2). Survival after cancer diagnosis did not differ between ADC and NADC. Advanced age was associated with NADC (P < 0.01 for trend) and increased mortality in ADC (age ≥ 50 years adjusted hazard ratio, 2.21; 95% CI, 1.00–4.89). Conclusions: Rates of ADC decreased while NADC increased within this cohort. Several NADC occurred at rates significantly higher than expected. Screening and suspicion for NADC should increase in care for HIV-infected patients.Keywords
This publication has 29 references indexed in Scilit:
- Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/μl when viral replication is suppressedAIDS, 2007
- HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of SmokingClinical Infectious Diseases, 2007
- Trends in cancer risk among people with AIDS in the United States 1980–2002AIDS, 2006
- Provision of General and HIV-Specific Health Maintenance in Middle Aged and Older Patients in an Urban HIV ClinicAIDS Patient Care and STDs, 2006
- Elevated Incidence of Lung Cancer Among HIV-Infected IndividualsJournal of Clinical Oncology, 2006
- AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral TherapyThe Oncologist, 2005
- Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDSInternational Journal of Epidemiology, 2004
- Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected PatientsJournal of Clinical Oncology, 2003
- Trends in Causes of Death among Persons with Acquired Immunodeficiency Syndrome in the Era of Highly Active Antiretroviral Therapy, San Francisco, 1994–1998The Journal of Infectious Diseases, 2002
- Combination Antiretroviral Therapy and Recent Declines in AIDS Incidence and MortalityThe Journal of Infectious Diseases, 1999